Draft:Center of Excellence for Emerging and Zoonotic Animal Diseases
Submission declined on 1 April 2025 by Sophisticatedevening (talk).
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
| ![]() |
Submission declined on 13 October 2024 by Encoded (talk). This draft's references do not show that the subject qualifies for a Wikipedia article. In summary, the draft needs multiple published sources that are:
Please ensure the article is formatted in an encyclopaedic manner. Declined by Encoded 6 months ago. | ![]() |
Submission declined on 24 September 2024 by Bobby Cohn (talk). This draft's references do not show that the subject qualifies for a Wikipedia article. In summary, the draft needs multiple published sources that are: Declined by Bobby Cohn 7 months ago.
| ![]() |
Since its creation in 2010, the Center of Excellence for Emerging and Zoonotic Animal Diseases (CEEZAD) at Kansas State University has undertaken the mission of protecting the nation’s public health and agricultural sectors. The Department of Homeland Security designated CEEZAD to fight a threat posed by high-consequence foreign animal, emerging and zoonotic disease threats.1
CEEZAD’s research efforts are directed by Dr. Juergen A. Richt, Regents Distinguished Professor at Kansas State University.2 CEEZAD is housed within the College of Veterinary Medicine at Kansas State University.3
CEEZAD scientists work to develop novel, safe, efficacious, and DIVA-compatible vaccines for prevention and control of high-impact emerging and zoonotic diseases that can be manufactured in the U.S.4
They also focus on development and expansion of technologies and platforms for laboratory and point-of-need pathogen detection.5
In order to facilitate the ability to predict high-consequence disease behavior in the U.S., they develop models to aid prevention or outbreak control.6
CEEZAD also develops and presents education and training programs for students, veterinarians, first responders, and researchers who may come in contact with high-impact animal diseases and animal emergencies.7
CEEZAD’s director, Dr. Juergen A. Richt, is an internationally recognized expert in virology who has been cited for his expertise in The New YorkTimes 8, 9, El Pais 10, National Public Radio11, and Fortune.12
Since the arrival of the SARS-CoV2 pandemic in 2020, CEEZAD scientists have undertaken dozens of research projects designed to mitigate the impact of the virus’s spread.13
Since 2011, CEEZAD scientists have published more than 250 refereed articles in major scientific journals reporting on the findings of their studies. A few examples of this research during the past few years include:
“H5N1 clade 2.3.4.4b dynamics in experimentally infected calves and cows.” Research provided evidence that in addition to H5N1 B3.13, other HPAIV H5N1 strains have the potential to replicate in the udder of cows and that milk and milking procedures, rather than respiratory spread, are likely the primary routes of H5N1 transmission between cattle.14
“Experimental co-infection of calves with SARS-CoV-2 Delta and Omicron variants of concern.” The findings suggest that cattle are more permissive to infection with SARS-CoV-2 Delta than Omicron BA.2 and Wuhan-like isolates but, in the absence of horizontal transmission, are not likely to be reservoir hosts for currently circulating SARS-CoV-2 variants.15
“Rift Valley Fever virus M and L genome segment detection: a comparison of field-deployable reverse transcription insulated isothermal PCR (RT-iiPCR) and laboratory-based multiplex reverse transcription real-time PCR.” This research concludes that the POCKIT dual-gene RVFV detection strategy can provide reliable, sensitive, and specific point-of-need viral RNA detection. Moreover, the field detection of RVFV in vectors or susceptible animal species can aid in the surveillance and epidemiological studies to better understand and control RVFV outbreaks. Journal of Clinical Microbiology, March 2024.16
2023 International African Swine Fever Workshop: Critical Issues That Need to be Addressed for ASF Control.17
Identification of Host Factors for Rift Valley Fever Phlebovirus 18
Fomite Transmission of SARS-CoV-2 and Its Contributing Factors19
Stability of SARS-CoV-2 in Biological Fluids of Animals20
Bison, Elk and Other Captive Wildlife Species Humoral Immune Responses against SARS-CoV-21
Experimental Inoculation of pigs with monkeypox virus results in protective infection and transmission to sentinels.22
Current scenario of viral diseases and vaccination strategies of cattle In Turkey.23
Development of an Indirect ELISA for the Detection of SARS-CoV-2 Antibodies in Cats. 24
Emergence, Evolution and Pathogenicity of Influenza A(H7N4) Virus in Shorebirds in China25
References
[edit]1. Centers of Excellence | Homeland Security (dhs.gov)
2. Jürgen A. Richt (k-state.edu)
3. CEEZAD | Kansas State University
4. About | CEEZAD
5. About | CEEZAD
6. About | CEEZAD
7. About | CEEZAD
8. How Does Bird Flu Spread in Cows? Experiment Yields Some ‘Good News.’ - The New York Times
9. How U.S. Farms Could Start a Bird Flu Pandemic - The New York Times
10. Experiment confirms that bird flu in the US is spread by milking procedures | Health | EL PAÍS English
11. Scientists warn of the increased dangers of a new bird flu strain | WRVO Public Media
12. New bird flu variant found in Nevada dairy cows has experts sounding alarms: ‘We have never been closer to a pandemic from this virus’
13. sars cov-2 richt - Search Results - PubMed (nih.gov)
14. Nature 2024 Sep 25
15. Emerging Microbes Infections, December 2024
16. Journal of Clinical Microbiology, March 2024
17. https://pubmed.ncbi.nlm.nih.gov/38275939/#:~:text=Viruses,doi%3A%2010.3390/v16010004.
18. https://pubmed.ncbi.nlm.nih.gov/38005928/#:~:text=Viruses,doi%3A%2010.3390/v15112251.
19. https://pubmed.ncbi.nlm.nih.gov/36986286/#:~:text=Pathogens,doi%3A%2010.3390/pathogens12030364.
20. https://pubmed.ncbi.nlm.nih.gov/36992470/#:~:text=Viruses,doi%3A%2010.3390/v15030761.
21. https://pubmed.ncbi.nlm.nih.gov/39409778/#:~:text=Animals%20(Basel),doi%3A%2010.3390/ani14192829.
22. https://pubmed.ncbi.nlm.nih.gov/38712637/#:~:text=Emerg%20Microbes%20Infect,2024%20Jun%2011.
23. https://pubmed.ncbi.nlm.nih.gov/36099365/#:~:text=Infect%20Dev%20Ctries,10.3855/jidc.14767.
24. https://pubmed.ncbi.nlm.nih.gov/35754530/#:~:text=Front%20Vet%20Sci,eCollection%202022.
25. https://pubmed.ncbi.nlm.nih.gov/34787451/#:~:text=J%20Virol,2021%20Nov%2017.
- in-depth (not just brief mentions about the subject or routine announcements)
- reliable
- secondary
- strictly independent of the subject
Make sure you add references that meet all four of these criteria before resubmitting. Learn about mistakes to avoid when addressing this issue. If no additional references exist, the subject is not suitable for Wikipedia.